PPARGC1A and fatty liver disease: Moreover, PRMT1 reduces high-fat diet-induced hepatic steatosis by increasing PGC-1α expression through the recruitment of HNF-4α to the PGC-1α promoter, thereby promoting fatty acid oxidation [35].